The current study suggests that NFIX mutations triggering or evading NMD can lead to two different clinical phenotypes, Malan syndrome or Ma Shi syndrome, with Malan syndrome having overgrowth as the main phenotype (Makker et al., 2024) caused by a major NFIX single-dose insufficiency. Here, NFIX is linked to Malan overgrowth syndrome.